Terms: = Ovarian cancer AND CDH11, OB, 1009, ENSG00000140937, CAD11, P55287 AND Treatment
14 results:
1. Hereditary Breast and ovarian cancer: An Updated Primer for OB/GYNs.
Bellcross CA
Obstet Gynecol Clin North Am; 2022 Mar; 49(1):117-147. PubMed ID: 35168766
[TBL] [Abstract] [Full Text] [Related]
2. MCM8IP activates the MCM8-9 helicase to promote DNA synthesis and homologous recombination upon DNA damage.
Huang JW; Acharya A; Taglialatela A; Nambiar TS; Cuella-Martin R; Leuzzi G; Hayward SB; Joseph SA; Brunette GJ; Anand R; Soni RK; Clark NL; Bernstein KA; Cejka P; Ciccia A
Nat Commun; 2020 Jun; 11(1):2948. PubMed ID: 32528060
[TBL] [Abstract] [Full Text] [Related]
3. Leptin induces matrix metalloproteinase 7 expression to promote ovarian cancer cell invasion by activating ERK and JNK pathways.
Ghasemi A; Hashemy SI; Aghaei M; Panjehpour M
J Cell Biochem; 2018 Feb; 119(2):2333-2344. PubMed ID: 28885729
[TBL] [Abstract] [Full Text] [Related]
4. RhoA/ROCK pathway mediates leptin-induced uPA expression to promote cell invasion in ovarian cancer cells.
Ghasemi A; Hashemy SI; Aghaei M; Panjehpour M
Cell Signal; 2017 Apr; 32():104-114. PubMed ID: 28104444
[TBL] [Abstract] [Full Text] [Related]
5. Sexual Health in Women Affected by cancer: Focus on Sexual Pain.
Coady D; Kennedy V
Obstet Gynecol; 2016 Oct; 128(4):775-91. PubMed ID: 27607852
[TBL] [Abstract] [Full Text] [Related]
6. High levels of pretreatment CA125 are associated to improved survival in high grade serous ovarian carcinoma.
Morales-Vásquez F; Pedernera E; Reynaga-Obregón J; López-Basave HN; Gómora MJ; Carlón E; Cárdenas S; Silva-Ayala R; Almaraz M; Méndez C
J Ovarian Res; 2016 Jul; 9(1):41. PubMed ID: 27388275
[TBL] [Abstract] [Full Text] [Related]
7. Prechemotherapy antimullerian hormone, age, and body size predict timing of return of ovarian function in young breast cancer patients.
Su HC; Haunschild C; Chung K; Komrokian S; Boles S; Sammel MD; DeMichele A
Cancer; 2014 Dec; 120(23):3691-8. PubMed ID: 25081546
[TBL] [Abstract] [Full Text] [Related]
8. Involvement of gynecologic oncologists in the treatment of patients with a suspicious ovarian mass.
Goff BA; Miller JW; Matthews B; Trivers KF; Andrilla CH; Lishner DM; Baldwin LM
Obstet Gynecol; 2011 Oct; 118(4):854-62. PubMed ID: 21934449
[TBL] [Abstract] [Full Text] [Related]
9. Advances in ovarian cancer screening: health and medicine for women: a multidisciplinary, evidence-based review of mid-life health concerns.
Ahmad S
Yale J Biol Med; 2011 Mar; 84(1):47-9. PubMed ID: 21451785
[TBL] [Abstract] [Full Text] [Related]
10. ovarian tumors in children and adolescents--a clinical study of 52 patients in a university hospital.
Al Jama FE; Al Ghamdi AA; Gasim T; Al Dakhiel SA; Rahman J; Rahman MS
J Pediatr Adolesc Gynecol; 2011 Feb; 24(1):25-8. PubMed ID: 20709583
[TBL] [Abstract] [Full Text] [Related]
11. Expression of leptin receptors and potential effects of leptin on the cell growth and activation of mitogen-activated protein kinases in ovarian cancer cells.
Choi JH; Park SH; Leung PC; Choi KC
J Clin Endocrinol Metab; 2005 Jan; 90(1):207-10. PubMed ID: 15522945
[TBL] [Abstract] [Full Text] [Related]
12. Laparoscopic extracorporeal oophorectomy and ovarian cystectomy in second trimester pregnant obese patients.
Chung MK; Chung RP
JSLS; 2001; 5(3):273-7. PubMed ID: 11548835
[TBL] [Abstract] [Full Text] [Related]
13. Biological evaluation of a lipid-mobilizing factor isolated from the urine of cancer patients.
Hirai K; Hussey HJ; Barber MD; Price SA; Tisdale MJ
Cancer Res; 1998 Jun; 58(11):2359-65. PubMed ID: 9622075
[TBL] [Abstract] [Full Text] [Related]
14. [The testicular feminization syndrome--a report of 9 cases].
Sirakov M; Kolarov G; Veltova L; Nalbanski B
Akush Ginekol (Sofiia); 1997; 36(2):22-4. PubMed ID: 9471897
[TBL] [Abstract] [Full Text] [Related]
